Private Equity/Health, consumer, tech services
Stakeboat Capital logo

Stakeboat Capital

Growth (SME) fund research profile

Stakeboat Capital is a value-oriented Indian mid-market private-equity manager investing through control, co-control and buyout transactions, alongside structured instruments. It focuses on healthcare and life sciences, industrials and manufacturing, and B2B technology and business services.

At a glance

Founded
2016
Footprint
Bengaluru
Stage
Growth (SME)

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

Stakeboat Capital uses a growth (sme) approach across Health, consumer, tech services.

Current evidence

Stakeboat’s current portfolio page identifies active investments in Ozonetel, DVARA KGFS, Ferfier, DiFACTO, Economy Process Solutions, Botanic Healthcare and Quick Clean, alongside partial or full exits from LeadSquared, Newgen KnowledgeWorks, Sukino, Sankalp Semiconductor and Leixir Dental Lab Group. The manager’s current AIF disclosure lists Fund I, Fund II and a GIFT City Fund, and its team page names Chandrasekar Kandasamy as Managing Partner.

Strategy

Growth (SME)

Sector focus

Health, consumer, tech services

AIF structure context

Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.

Current signal

Stakeboat’s current portfolio page identifies active investments in Ozonetel, DVARA KGFS, Ferfier, DiFACTO, Economy Process Solutions, Botanic Healthcare and Quick Clean, alongside partial or full exits from LeadSquared, Newgen KnowledgeWorks, Sukino, Sankalp Semiconductor and Leixir Dental Lab Group. The manager’s current AIF disclosure lists Fund I, Fund II and a GIFT City Fund, and its team page names Chandrasekar Kandasamy as Managing Partner.

Investor questions

Stakeboat Capital research questions

What is Stakeboat Capital's investment strategy?

Stakeboat Capital is covered in Rupeia's private equity research universe. The current public record describes the strategy as Growth (SME), with a sector focus of Health, consumer, tech services. The profile should be read with the linked source trail and Typical route: Category II AIF context.

What portfolio evidence is available for Stakeboat Capital?

The profile displays only company or asset names attributable to Stakeboat Capital in the reviewed public sources: DVARA KGFS, LeadSquared, Ozonetel, Ferfier Technologies, DiFACTO Robotics, Economy Process Solutions, Botanic Healthcare, Quick Clean, Newgen KnowledgeWorks, Sukino, Sankalp Semiconductor, Leixir Dental Lab Group. It does not represent a complete current portfolio unless the manager has published one.

What is known about Stakeboat Capital's performance or track record?

Managing Partner Chandra Kandasamy states that he has sourced, led or managed 68 transactions, exited 66 and distributed 2.4x cash back to investors at a 20%+ dollar IRR across his prior track record. This is manager commentary, not a disclosed fund-level return. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are Stakeboat Capital's fund size, fees and minimum investment?

Public fund size: Stakeboat publicly identifies Fund I, Fund II and a GIFT City Fund but does not disclose current corpus sizes on the reviewed pages.. Public terms or access information: Lower-middle-market control, co-control, buyout and structured-capital investments; vehicle-specific cheque sizes and reserves are not consistently public.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on Stakeboat Capital's investment team?

The current source record names Chandrasekar (Chandra) Kandasamy (Managing Partner); Srinivas Baratam (Managing Director); Girish Patil (Managing Director); Deepti Malik (Managing Director). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with Stakeboat Capital?

Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: Current fund corpus and fund-level net returns are not publicly disclosed; the manager’s historic 2.4x/20%+ track record is labelled as prior-manager commentary rather than a current fund result..

What is the latest public update on Stakeboat Capital?

2026-08-31: Stakeboat’s current portfolio page identifies active investments in Ozonetel, DVARA KGFS, Ferfier, DiFACTO, Economy Process Solutions, Botanic Healthcare and Quick Clean, alongside partial or full exits from LeadSquared, Newgen KnowledgeWorks, Sukino, Sankalp Semiconductor and Leixir Dental Lab Group. The manager’s current AIF disclosure lists Fund I, Fund II and a GIFT City Fund, and its team page names Chandrasekar Kandasamy as Managing Partner.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →